Osaic Holdings
CMPX icon

Osaic Holdings’s Compass Therapeutics CMPX Stock Holding History

Osaic Holdings’s Portfolio CMPX Stock Details CMPX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$91.9K Buy
41,965
+27,287
+186% +$80.6K ﹤0.01% 5019
2026
Q1 		$77.6K Buy
14,678
+14,621
+25,651% +$84.4K ﹤0.01% 4864
2025
Q4 		$306 Buy
+57
New +$263 ﹤0.01% 7518
2023
Q1 		– Sell
-100
Closed -$1K – 7509
2022
Q4 		$1K Hold
100
– – ﹤0.01% 6849
2022
Q3 		$0 Hold
100
– – ﹤0.01% 7282
2022
Q2 		$0 Buy
+100
New +$217 ﹤0.01% 7368

Other funds holding CMPX

TCM
Tang Capital Management San Diego, California $2.2B AUM 156.35% 1-Year Est. Return
O
OrbiMed New York $5.4B AUM 163.13% 1-Year Est. Return
SCM
Suvretta Capital Management New York $5.47B AUM 131.34% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
ES
Enavate Sciences Menlo Park, California $345M AUM 134.64% 1-Year Est. Return
VC
Vivo Capital Palo Alto, California $1.1B AUM 799.93% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
PAI
Palo Alto Investors Palo Alto, California $724M AUM 96.91% 1-Year Est. Return
Millennium Management
Millennium Management New York $276B AUM 44.8% 1-Year Est. Return

Osaic Holdings's CMPX Position: Q2 2026 in Review

Osaic Holdings increased its Compass Therapeutics (CMPX) stake by 186% in Q2 2026, buying an estimated $80.6K and bringing the position to 41,965 shares worth $91.9K. The position accounts for ﹤0.01% of the portfolio, ranked #5019.

Osaic Holdings first reported a position in CMPX in Q2 2022 and has held it in 6 quarters since. 215 funds tracked by Wall St. Rank hold CMPX as of Q2 2026.

  • Osaic Holdings held 41,965 shares of Compass Therapeutics worth $91.9K as of Q2 2026.
  • Osaic Holdings bought 27,287 Compass Therapeutics shares in Q2 2026, an estimated $80.6K.
  • Compass Therapeutics made up ﹤0.01% of Osaic Holdings's portfolio in Q2 2026, its #5019 holding.
  • Osaic Holdings first reported a position in Compass Therapeutics in Q2 2022 and has held it in 6 quarters since.
  • 215 funds tracked by Wall St. Rank held Compass Therapeutics as of Q2 2026.

Based on Osaic Holdings's 13F filing for Q2 2026, filed 14 Aug 2026.